Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Vaughn L. Culbertson"'
Autor:
Dong Xu, Alexandrea G. Ham, Rickey D. Tivis, Matthew L. Caylor, Aoxiang Tao, Steve T. Flynn, Peter J. Economen, Hung K. Dang, Royal W. Johnson, Vaughn L. Culbertson
Publikováno v:
EBioMedicine, Vol 26, Iss C, Pp 132-137 (2017)
In 2009 the U.S. Food and Drug Administration (FDA) placed a black box warning on metoclopramide (MCP) due to the increased risks and prevalence of tardive dyskinesia (TD). In this study, we developed a multi-step biomedical informatics screening (MS
Externí odkaz:
https://doaj.org/article/713a7fcc4bc342719541ede89167f10b
Autor:
Matthew L. Caylor, Vaughn L. Culbertson, Dong Xu, Grayson C. Bosen, Shaikh Emdadur Rahman, Megan M. Echevarria
Publikováno v:
Pharmacotherapy
Study objective Serotonergic adverse drug events (ADEs) are caused by enhanced intrasynaptic concentrations of 5-hydroxytryptamine (5-HT). No systematic process currently exists for evaluating cumulative 5-HT and off-target toxicity of serotonergic d
Autor:
Rickey D. Tivis, Peter J. Economen, Hung K. Dang, Royal W. Johnson, Alexandrea G. Ham, Steve T. Flynn, Dong Xu, Aoxiang Tao, Matthew L. Caylor, Vaughn L. Culbertson
Publikováno v:
EBioMedicine, Vol 26, Iss C, Pp 132-137 (2017)
EBioMedicine
EBioMedicine
In 2009 the U.S. Food and Drug Administration (FDA) placed a black box warning on metoclopramide (MCP) due to the increased risks and prevalence of tardive dyskinesia (TD). In this study, we developed a multi-step biomedical informatics screening (MS
Publikováno v:
Pharmacotherapy. 39(2)
STUDY OBJECTIVE: Numerous medications interact at serotonin (5-hydroxytryptamine [5-HT]) receptors directly or through off-target interactions, causing mild to severe serotonergic adverse drug events (ADEs), particularly among the elderly. Our object
Autor:
Angela D Meeker, Vaughn L. Culbertson, Craig M Kelley, Paul S. Cady, Rex W. Force, Wendy S Force
Publikováno v:
Annals of Pharmacotherapy. 37:490-493
BACKGROUND: Assimilation of vitamin B12 from dietary sources requires gastric acid. By decreasing acid production, the proton pump inhibitors (PPIs) and histamine2 (H2)-blockers may reduce vitamin B12 absorption. OBJECTIVE: To determine whether chron
Publikováno v:
American healthdrug benefits. 3(4)
It has been estimated that more than $8 billion is spent annually on the management of breast cancer in the United States. The taxane chemotherapeutic agents are cornerstones in the treatment of breast cancer, yet no study has assessed whether the ch
Publikováno v:
The Annals of pharmacotherapy. 44(9)
Background: In late 2007, the Food and Drug Administration (FDA) held public hearings exploring the establishment of a new behind-the-counter (BTC) drug program. However, little is known about the views ol pharmacists regarding such a program. Object
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 45(5)
To estimate frequencies of potential errors involving similarly named drugs using a retrospective claims database and measure the association between frequencies of potential errors and two measures of drug name similarity, edit distance (minimum num
Autor:
Rex W, Force, Angela D, Meeker, Paul S, Cady, Vaughn L, Culbertson, Wendy S, Force, Craig M, Kelley
Publikováno v:
The Annals of pharmacotherapy. 37(4)
Assimilation of vitamin B(12) from dietary sources requires gastric acid. By decreasing acid production, the proton pump inhibitors (PPIs) and histamine(2) (H(2))-blockers may reduce vitamin B(12) absorption.To determine whether chronic acid suppress
Publikováno v:
Encyclopedia of Clinical Pharmacy ISBN: 0824706080
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::538ee7b58e6ffe0fbee0b56096b1601b
https://doi.org/10.3109/9780824706081.107
https://doi.org/10.3109/9780824706081.107